JBIO
Jade Biosciences, Inc.
14.10$
-0.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +12.0% | +0.0% | +0.0% | – | – | -100.0% | – | +140.0% | -25.0% | +0.0% | +0.0% | – | |
| – | – | – | – | – | +4,451.9% | +97.2% | +60.8% | +10.3% | +118.8% | -21.2% | +83.7% | – | |
| – | +118.5% | -220.9% | – | +630.8% | -74.0% | -27.2% | +15.4% | -158.4% | – | – | -112.6% | – | |
| – | +100.0% | -100.0% | – | – | – | – | – | -58.1% | -94.7% | -100.0% | – | – | |
| – | – | +56.4% | +103.8% | -249.1% | – | – | – | +109,244.1% | -34.0% | -91.4% | +1,052.7% | – | |
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | |
| – | +2,215.0% | +1.7% | +5,076.2% | +288.7% | -102.9% | -74.7% | – | -100.0% | – | -100.5% | – | – | |
| – | – | – | – | +300.8% | -121.1% | – | – | -199.9% | – | -187.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.